fig2

From: Challenges in determining the malignant potential of atypical neurofibromas (aNF) using histopathologic features and the potential need for CDKN2A/2B testing: a case report

Challenges in determining the malignant potential of atypical neurofibromas (aNF) using histopathologic features and the potential need for <i>CDKN2A/2B</i> testing: a case report

Figure 2. MRI images and volume trends of resected tumors. Axial STIR MRI images show the evolution of the resected tumors (white arrows) up to the time of resection (A, C, E, G). Volume of each resected lesion over time where available (B, D, F). Symbols on the graphs correspond to imaging measurements, with the larger circles matching the MRI images provided on the left and the red color indicating selumetinib therapy. For case 4 (G), no longitudinal volumetric data are available. MRI: Magnetic Resonance imaging; STIR: short T1-inversion recovery.

fig2

Portico

Portico